ReviewThe Microbial Toxin microcin (cas 1403-96-9) B17: Prospects for the Development of New Antibacterial Agents
-
Add time:09/03/2019 Source:sciencedirect.com
microcin (cas 1403-96-9) B17 (MccB17) is an antibacterial peptide produced by strains of Escherichia coli harboring the plasmid-borne mccB17 operon. MccB17 possesses many notable features. It is able to stabilize the transient DNA gyrase–DNA cleavage complex, a very efficient mode of action shared with the highly successful fluoroquinolone drugs. MccB17 stabilizes this complex by a distinct mechanism making it potentially valuable in the fight against bacterial antibiotic resistance. MccB17 was the first compound discovered from the thiazole/oxazole-modified microcins family and the linear azole-containing peptides; these ribosomal peptides are post-translationally modified to convert serine and cysteine residues into oxazole and thiazole rings. These chemical moieties are found in many other bioactive compounds like the vitamin thiamine, the anti-cancer drug bleomycin, the antibacterial sulfathiazole and the antiviral nitazoxanide. Therefore, the biosynthetic machinery that produces these azole rings is noteworthy as a general method to create bioactive compounds. Our knowledge of MccB17 now extends to many aspects of antibacterial–bacteria interactions: production, transport, interaction with its target, and resistance mechanisms; this knowledge has wide potential applicability. After a long time with limited progress on MccB17, recent publications have addressed critical aspects of MccB17 biosynthesis as well as an explosion in the discovery of new related compounds in the thiazole/oxazole-modified microcins/linear azole-containing peptides family. It is therefore timely to summarize the evidence gathered over more than 40 years about this still enigmatic molecule and place it in the wider context of antibacterials.
We also recommend Trading Suppliers and Manufacturers of microcin (cas 1403-96-9). Pls Click Website Link as below: cas 1403-96-9 suppliers
Prev:Chapter Forty - microcin (cas 1403-96-9) SF608
Next:Cytochromes bd-I and bo3 are essential for the bactericidal effect of microcin (cas 1403-96-9) J25 on Escherichia coli cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Structural characterization of microcin (cas 1403-96-9) E492 amyloid formation: Identification of the precursors09/10/2019
- Research papermicrocin (cas 1403-96-9) J25 inhibits ubiquinol oxidase activity of purified cytochrome bd-I from Escherichia coli09/09/2019
- ArticleThe Origins of Specificity in the microcin (cas 1403-96-9)-Processing Protease TldD/E09/08/2019
- ArticleArchitecture of microcin (cas 1403-96-9) B17 Synthetase: An Octameric Protein Complex Converting a Ribosomally Synthesized Peptide into a DNA Gyrase Poison09/07/2019
- The antimicrobial peptide microcin (cas 1403-96-9) J25 stabilizes the gel phase of bacterial model membranes09/06/2019
- microcin (cas 1403-96-9)s and urovirulence in Escherichia coli09/05/2019
- Cytochromes bd-I and bo3 are essential for the bactericidal effect of microcin (cas 1403-96-9) J25 on Escherichia coli cells09/04/2019
- Chapter Forty - microcin (cas 1403-96-9) SF60809/02/2019
- Multifaceted ABC transporters associated to microcin (cas 1403-96-9) and bacteriocin export09/01/2019


